• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1 型糖尿病意大利患者心血管疾病风险预测中 Steno 型 1 风险引擎的性能。

Performance of the Steno type 1 risk engine for cardiovascular disease prediction in Italian patients with type 1 diabetes.

机构信息

Department of Medicine, University of Padova, 35128 Padova, Italy.

Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, 35128, Padova, Italy.

出版信息

Nutr Metab Cardiovasc Dis. 2020 Sep 24;30(10):1813-1819. doi: 10.1016/j.numecd.2020.07.006. Epub 2020 Jul 11.

DOI:10.1016/j.numecd.2020.07.006
PMID:32807633
Abstract

BACKGROUND AND AIMS

Premature cardiovascular disease cause excess mortality in type 1 diabetes (T1D). The Steno T1D Risk Engine was developed and validated in northern European countries but its validity in other populations is unknown. We evaluated the performance of the Steno T1D Risk Engine in Italian patients with T1D.

MATERIALS AND METHODS

We included patients with T1D with a baseline visit between July 2013 and April 2014, who were free of cardiovascular disease and had complete information to estimate risk. The estimated cardiovascular risk score was compared with the 5-year rate of cardiovascular events by means of logistic regression.

RESULTS

Among 223 patients (mean age 43 ± 13 years, 34.5% male, mean duration of diabetes 22 ± 12 years) the mean estimated cardiovascular risk at 5 years was 5.9% (95% C.I. 5.2-6.5%). At baseline, high estimated risk discriminated the presence of asymptomatic atherosclerosis better than microangiopathy, and was not associated with markers of inflammation or endothelial activation. After a mean follow-up of 4.7 ± 0.5 years, only 3 cardiovascular events were observed and nonetheless the risk score was significantly associated with their incidence (OR 1.22; 95% C.I. 1.08-1.39, p = 0.001). However, the observed event rate was significantly lower than the estimated one (3 vs 13; 95% C.I. 12-14; p < 0.001).

CONCLUSION

The Steno T1D Risk Score identified subjects with subclinical atherosclerosis and high cardiovascular risk in an Italian T1D population. However, the absolute risk was significantly overestimated. Further studies in larger population are needed to confirm these results.

摘要

背景与目的

1 型糖尿病(T1D)患者存在过早发生心血管疾病,导致死亡率增加。Steno T1D 风险引擎在北欧国家开发和验证,但在其他人群中的有效性尚不清楚。我们评估了 Steno T1D 风险引擎在意大利 T1D 患者中的表现。

材料和方法

我们纳入了 2013 年 7 月至 2014 年 4 月间基线访视的、无心血管疾病且具有完整风险估计信息的 T1D 患者。使用逻辑回归比较了估计的心血管风险评分与 5 年内心血管事件的发生率。

结果

在 223 名患者(平均年龄 43 ± 13 岁,34.5%为男性,糖尿病病程平均为 22 ± 12 年)中,5 年的平均估计心血管风险为 5.9%(95%CI 5.2-6.5%)。在基线时,高估计风险比微血管病变更能预测无症状动脉粥样硬化的存在,并且与炎症或内皮激活标志物无关。平均随访 4.7 ± 0.5 年后,仅观察到 3 例心血管事件,但风险评分与事件发生率显著相关(OR 1.22;95%CI 1.08-1.39,p = 0.001)。然而,观察到的事件发生率明显低于估计的发生率(3 比 13;95%CI 12-14;p < 0.001)。

结论

Steno T1D 风险评分在意大利 T1D 人群中识别出了亚临床动脉粥样硬化和高心血管风险的患者。然而,绝对风险被显著高估。需要在更大的人群中进行进一步的研究来证实这些结果。

相似文献

1
Performance of the Steno type 1 risk engine for cardiovascular disease prediction in Italian patients with type 1 diabetes.1 型糖尿病意大利患者心血管疾病风险预测中 Steno 型 1 风险引擎的性能。
Nutr Metab Cardiovasc Dis. 2020 Sep 24;30(10):1813-1819. doi: 10.1016/j.numecd.2020.07.006. Epub 2020 Jul 11.
2
Arterial stiffness in patients with type 1 diabetes and its comparison to cardiovascular risk evaluation tools.1 型糖尿病患者的动脉僵硬度及其与心血管风险评估工具的比较。
Cardiovasc Diabetol. 2022 Jun 9;21(1):97. doi: 10.1186/s12933-022-01537-1.
3
Evaluation of cardiovascular risk in adults with type 1 diabetes: poor concordance between the 2019 ESC risk classification and 10-year cardiovascular risk prediction according to the Steno Type 1 Risk Engine.评估 1 型糖尿病成人的心血管风险:2019 ESC 风险分类与 Steno Type 1 Risk Engine 预测的 10 年心血管风险之间的一致性较差。
Cardiovasc Diabetol. 2020 Oct 3;19(1):166. doi: 10.1186/s12933-020-01137-x.
4
Comparison of coronary artery calcium score and cardiovascular risk-stratification by European Society of Cardiology Guidelines and Steno Type 1 Risk Engine in statin-naïve adults with type 1 diabetes.他汀类药物初治的 1 型糖尿病患者中,欧洲心脏病学会指南和 Steno Type 1 Risk Engine 评估的冠状动脉钙评分与心血管风险分层的比较。
J Diabetes Complications. 2023 Aug;37(8):108557. doi: 10.1016/j.jdiacomp.2023.108557. Epub 2023 Jul 10.
5
Use of the Steno T1 Risk Engine Identifies Preclinical Atherosclerosis Better Than Use of ESC/EASD-2019 in Adult Subjects With Type 1 Diabetes at High Risk.应用 Steno T1 Risk Engine 比 ESC/EASD-2019 更能在 1 型糖尿病高危成年患者中识别出亚临床动脉粥样硬化。
Diabetes Care. 2022 Oct 1;45(10):2412-2421. doi: 10.2337/dc22-0118.
6
Severe hypoglycemia and hypoglycemia awareness are associated with preclinical atherosclerosis in patients with type 1 diabetes without an estimated high cardiovascular risk.严重低血糖和低血糖意识与 1 型糖尿病患者的临床前动脉粥样硬化有关,这些患者估计没有高心血管风险。
Diabetes Metab Res Rev. 2024 Mar;40(3):e3785. doi: 10.1002/dmrr.3785.
7
Steno type 1 risk engine and preclinical atherosclerosis in Mediterranean individuals with type 1 diabetes.1型糖尿病地中海人群中的斯滕诺1型风险引擎与临床前期动脉粥样硬化
Diabetes Metab Res Rev. 2020 Oct;36(7):e3320. doi: 10.1002/dmrr.3320. Epub 2020 Apr 13.
8
Ambivalence about the selection of cardiovascular risk stratification tools: Evidence in a type 1 diabetes population.对心血管风险分层工具选择的矛盾态度:1型糖尿病患者群体的证据。
Diabetes Metab Syndr. 2019 May-Jun;13(3):2322-2327. doi: 10.1016/j.dsx.2019.05.024. Epub 2019 May 24.
9
Performance of 2019 ESC risk classification and the Steno type 1 risk engine in predicting cardiovascular events in adults with type 1 diabetes: A retrospective study.2019 ESC 风险分类和 Steno 1 型风险引擎在预测 1 型糖尿病成人心血管事件中的表现:一项回顾性研究。
Diabetes Res Clin Pract. 2022 Aug;190:110001. doi: 10.1016/j.diabres.2022.110001. Epub 2022 Jul 18.
10
Validity of a long-term cardiovascular disease risk prediction equation for low-incidence populations: the CAMUNI-MATISS Cohorts Collaboration study.低发病率人群长期心血管疾病风险预测方程的有效性:卡穆尼-马蒂斯队列合作研究
Eur J Prev Cardiol. 2015 Dec;22(12):1618-25. doi: 10.1177/2047487314563709. Epub 2014 Dec 11.

引用本文的文献

1
Cardiovascular Risk Prediction Scores in Type 1 Diabetes: A Systematic Review and Meta-Analysis.1型糖尿病的心血管风险预测评分:一项系统评价和荟萃分析
JACC Adv. 2024 Dec 17;4(1):101462. doi: 10.1016/j.jacadv.2024.101462. eCollection 2025 Jan.
2
Evaluation of the Steno Type 1 Risk Engine in predicting cardiovascular events in an ethnic mixed population of type 1 diabetes mellitus and its association with chronic microangiopathy complications.评估 Steno Type 1 风险引擎在预测 1 型糖尿病的种族混合人群中心血管事件中的作用及其与慢性微血管并发症的关系。
Cardiovasc Diabetol. 2024 Oct 22;23(1):374. doi: 10.1186/s12933-024-02460-3.
3
A comparative study of cardiovascular risk stratification methods in type 1 diabetes mellitus patients.
1型糖尿病患者心血管风险分层方法的比较研究
Diabetol Metab Syndr. 2024 Jan 9;16(1):10. doi: 10.1186/s13098-023-01224-5.
4
Arterial stiffness in patients with type 1 diabetes and its comparison to cardiovascular risk evaluation tools.1 型糖尿病患者的动脉僵硬度及其与心血管风险评估工具的比较。
Cardiovasc Diabetol. 2022 Jun 9;21(1):97. doi: 10.1186/s12933-022-01537-1.
5
Dyslipidaemia in Type 1 Diabetes: Molecular Mechanisms and Therapeutic Opportunities.1型糖尿病中的血脂异常:分子机制与治疗机遇
Biomedicines. 2021 Jul 16;9(7):826. doi: 10.3390/biomedicines9070826.
6
Cardiovascular Disease in Type 1 Diabetes Mellitus: Epidemiology and Management of Cardiovascular Risk.1型糖尿病中的心血管疾病:心血管风险的流行病学与管理
J Clin Med. 2021 Apr 20;10(8):1798. doi: 10.3390/jcm10081798.
7
Response to Comment on Garofolo et al. Insulin Resistance and Risk of Major Vascular Events and All-Cause Mortality in Type 1 Diabetes: A 10-Year Follow-up Study. Diabetes Care 2020;43:e139-e141.对关于加罗福洛等人的评论的回应。1型糖尿病患者的胰岛素抵抗与主要血管事件风险及全因死亡率:一项10年随访研究。《糖尿病护理》2020年;43:e139 - e141。
Diabetes Care. 2021 Apr;44(4):e81. doi: 10.2337/dci20-0079.
8
Evaluation of cardiovascular risk in adults with type 1 diabetes: poor concordance between the 2019 ESC risk classification and 10-year cardiovascular risk prediction according to the Steno Type 1 Risk Engine.评估 1 型糖尿病成人的心血管风险:2019 ESC 风险分类与 Steno Type 1 Risk Engine 预测的 10 年心血管风险之间的一致性较差。
Cardiovasc Diabetol. 2020 Oct 3;19(1):166. doi: 10.1186/s12933-020-01137-x.